| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.09B | 37.58B | 35.44B | 30.89B | 16.81B | 13.59B |
| Gross Profit | 5.50B | 4.83B | 5.24B | 4.62B | -3.00M | -2.98B |
| EBITDA | 4.66B | 3.60B | 5.33B | 3.85B | 31.00M | -5.49B |
| Net Income | 1.64B | 1.38B | 1.67B | 791.00M | -2.19B | -6.72B |
Balance Sheet | ||||||
| Total Assets | 48.83B | 48.16B | 46.16B | 44.26B | 43.49B | 40.07B |
| Cash, Cash Equivalents and Short-Term Investments | 9.38B | 8.49B | 8.27B | 8.30B | 7.67B | 5.46B |
| Total Debt | 14.46B | 14.23B | 13.95B | 15.17B | 16.69B | 15.38B |
| Total Liabilities | 37.41B | 36.56B | 36.45B | 35.78B | 39.00B | 38.69B |
| Stockholders Equity | 11.36B | 11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | ||||||
| Free Cash Flow | 639.00M | -6.00M | 659.00M | 2.66B | -700.00M | -3.58B |
| Operating Cash Flow | 4.36B | 3.89B | 4.71B | 5.17B | 618.00M | -2.33B |
| Investing Cash Flow | -3.21B | -2.33B | -2.94B | -3.44B | -3.02B | -2.34B |
| Financing Cash Flow | -1.19B | -1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €9.33B | 5.25 | 15.13% | 3.63% | 5.95% | 82.99% | |
76 Outperform | €13.60B | 7.64 | 10.20% | 5.79% | -7.11% | -30.83% | |
73 Outperform | €6.93B | 17.53 | 9.56% | ― | 0.11% | 2.58% | |
69 Neutral | €3.16B | 8.89 | 13.91% | 5.23% | 8.60% | 20.38% | |
67 Neutral | €3.16B | 12.31 | 13.91% | 3.84% | 8.60% | 20.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | €2.07B | 58.87 | 5.78% | 0.47% | 13.44% | 113.13% |